Frontier IP's The Vaccine Group to begin animal coronavirus vaccine trials 'imminently'

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's  Andrew Scott its portfolio company The Vaccine Group is to 'imminently' start trials of its coronavirus vaccine in animals.

Crabb says the idea is to develop an animal inoculation that would prevent the spread of coronavirus from animal to human.

TVG's also working on a number of other animal vaccines including bovine tuberculosis and African Swine Fever.